Stocks in play: KITS Eyecare Ltd.
Is providing selected preliminary unaudited results for its first quarter ended March 31, 2024. Q1 2024 revenue grew to over $34 million, representing a 23% year-over-year increase and a 7% increase sequentially. The company finished the quarter with a healthy cash balance of approximately $18 million. KITS Eyecare Ltd. shares T.KITS are trading up $0.50 at $6.55.
Read:
Global Efforts Intensify to Address Surging Young Adult Colorectal and Anal Cancer Rates
Harnessing AI's $4.4 Trillion Potential Reshapes the Tech Industry Landscape
Critical Push for US Domestic Nickel Needed to Halt Total Reliance on Questionable Foreign Imports
How Argentina’s New Power Moves Look to Lure Even More Lithium Interest Towards the Country
How Recent Biotech Breakthroughs Are Changing the Fight Against Breast Cancer